[HTML][HTML] Branch retinal vein occlusion: Treatment outcomes according to the retinal nonperfusion area, clinical subtype, and crossing pattern
Y Iida-Miwa, Y Muraoka, Y Iida, S Ooto, T Murakami… - Scientific reports, 2019 - nature.com
… In the present study, six of the 58 eyes (10.3%) showed retinal or … We excluded eyes in which
the occluded site was located … , we excluded eyes with hemicentral retinal vein occlusion, …
the occluded site was located … , we excluded eyes with hemicentral retinal vein occlusion, …
Aqueous humor inflammatory cytokine levels and choroidal thickness in patients with macular edema associated with branch retinal vein occlusion
Y An, SP Park, YK Kim - International Ophthalmology, 2021 - Springer
… reported prevalence rates were ranging from 0.3 to 0.9% [1,2,3], and the incidence rate of …
The 15-year cumulative incidence of BRVO was 1.8% [4]. Most vision-threatening …
The 15-year cumulative incidence of BRVO was 1.8% [4]. Most vision-threatening …
[HTML][HTML] Etiological factors in young patients with retinal vein occlusion
S Nalcaci, C Degirmenci, C Akkin… - Pakistan Journal of …, 2019 - ncbi.nlm.nih.gov
… occlusion is at disc level in central and hemi-central vein occlusions, in branch retinal vein
occlusion (… The prevalences of BRVO and central retinal vein occlusion (CRVO) are about 0.6…
occlusion (… The prevalences of BRVO and central retinal vein occlusion (CRVO) are about 0.6…
[HTML][HTML] Factors associated with extremely poor visual outcomes in patients with central retinal vein occlusion
D Nagasato, Y Muraoka, R Osaka, Y Iida-Miwa… - Scientific Reports, 2020 - nature.com
… Central retinal vein occlusion (CRVO) is a common retinal vascular disorder. Because of …
of the central retinal vein, the retinal nonperfusion area (NPA) can extend to the entire retina 1 . …
of the central retinal vein, the retinal nonperfusion area (NPA) can extend to the entire retina 1 . …
[HTML][HTML] The development of risk factors and cytokines in retinal vein occlusion
Y Tang, Y Cheng, S Wang, Y Wang, P Liu… - Frontiers in Medicine, 2022 - frontiersin.org
… In the Beaver Dam Eye Study, higher creatinine was found to be a risk factor of RVO (98),
while in the Blue-mountain Eye Study, the creatinine was not (101). However, patients with …
while in the Blue-mountain Eye Study, the creatinine was not (101). However, patients with …
[HTML][HTML] Anti-VEGF reduces inflammatory features in macular edema secondary to retinal vein occlusion
HF Qin, FJ Shi, CY Zhang, DW Luo, SY Qin… - International Journal …, 2022 - ncbi.nlm.nih.gov
… The retinal vein occlusion (RVO) was comprised of both central retinal vein occlusion (CRVO,
n=14) and branch retinal vein occlusion (BRVO, n=14). Intravitreal injection of anti-VEGF …
n=14) and branch retinal vein occlusion (BRVO, n=14). Intravitreal injection of anti-VEGF …
Retinal vascular occlusions
A Gupta, R Bansal, A Sharma, A Kapil - Ophthalmic Signs in Practice of …, 2024 - Springer
… In the 15-year incidence and prevalence study of RVO (The Beaver dam eye study), the
significant risk factors for CRVO, apart from age, included glaucoma, history of diabetes, and use …
significant risk factors for CRVO, apart from age, included glaucoma, history of diabetes, and use …
Retinal vein occlusion: drug targets and therapeutic implications
A Arrigo, F Bandello - Expert Opinion on Therapeutic Targets, 2021 - Taylor & Francis
… : retinal vein occlusion, branch retinal vein occlusion, central retinal vein occlusion, ischemic
retinal vein occlusion, … retinal vein occlusion, hemiretinal vein occlusion, retinal vein …
retinal vein occlusion, … retinal vein occlusion, hemiretinal vein occlusion, retinal vein …
[HTML][HTML] Retinal blood flow as a predictor of recurrence of macular edema after intravitreal ranibizumab injection in central retinal vein occlusion
Y Takano, H Noma, K Yasuda, T Yamaguchi… - … Research, 2021 - karger.com
… [8] based on proteomic studies indicate that VEGF regulates a number of proteins involved
in formation of ME in retinal vein occlusion. Induction of VEGF by vascular occlusion was …
in formation of ME in retinal vein occlusion. Induction of VEGF by vascular occlusion was …
Prospective trial of treat-and-extend regimen with aflibercept for branch retinal vein occlusion: 1-year results of the PLATON trial
DG Park, WJ Jeong, JM Park, JY Kim, YS Ji… - Graefe's Archive for …, 2021 - Springer
… This study was based on the Prospective triaL of treat-and-… retinal vein OcclusioN (PLATON)
trial, which was a multicenter, noncomparative, open-label 72-week clinical trial. This study …
trial, which was a multicenter, noncomparative, open-label 72-week clinical trial. This study …